#211 The Weight Loss Drug Revolution: The Hottest Trend on Wall Street
This week, we unpack Hims & Hers introduction of discounted weight loss drugs and the impact these revolutionary pharmaceuticals have had on the broader market. Did you know Eli Lily developed the tech first and let their patent expire? Join Mike and Anne Marie as they discuss the transformative impact of AI voice…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Stock Club
See all episodes →
Chapters Group: Europe's Mini Constellation Software With Compounding Quality's Pieter Slegers
Ouster & Schaeffler: Two More Investicon Stock Picks, One Year Later | Stock Club 323
Two Overlooked AI Stocks Worth Knowing About
Similar episodes from other shows
More like Stock Club →
A New Name in Weight-Loss Drugs
Here's How the New Weight Loss Drugs Could Change Everything
Walmart’s Consumer Warning… And Eli Lilly’s Latest Tip Of The Scales 5/21/26
The Weight Loss Drug Revolution: Transforming Bodies and Reshaping Economies | The Global Brief
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.